nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2B—Etoposide—muscle cancer	0.653	0.745	CbGbCtD
Dexrazoxane—TOP2A—Etoposide—muscle cancer	0.133	0.151	CbGbCtD
Dexrazoxane—TOP2A—Doxorubicin—muscle cancer	0.0904	0.103	CbGbCtD
Dexrazoxane—TOP2B—embryo—muscle cancer	0.00296	0.133	CbGeAlD
Dexrazoxane—TOP2B—Teniposide—Etoposide—muscle cancer	0.00279	0.479	CbGdCrCtD
Dexrazoxane—TOP2B—smooth muscle tissue—muscle cancer	0.00233	0.104	CbGeAlD
Dexrazoxane—TOP2B—renal system—muscle cancer	0.00224	0.1	CbGeAlD
Dexrazoxane—TOP2B—cardiac atrium—muscle cancer	0.00201	0.0898	CbGeAlD
Dexrazoxane—TOP2B—tendon—muscle cancer	0.00175	0.0783	CbGeAlD
Dexrazoxane—TOP2B—bone marrow—muscle cancer	0.00169	0.0758	CbGeAlD
Dexrazoxane—TOP2B—vagina—muscle cancer	0.00162	0.0727	CbGeAlD
Dexrazoxane—TOP2B—head—muscle cancer	0.0015	0.0671	CbGeAlD
Dexrazoxane—TOP2B—testis—muscle cancer	0.00145	0.0648	CbGeAlD
Dexrazoxane—TOP2A—tendon—muscle cancer	0.00129	0.0576	CbGeAlD
Dexrazoxane—TOP2A—bone marrow—muscle cancer	0.00125	0.0558	CbGeAlD
Dexrazoxane—TOP2A—vagina—muscle cancer	0.00119	0.0534	CbGeAlD
Dexrazoxane—TOP2A—testis—muscle cancer	0.00106	0.0477	CbGeAlD
Dexrazoxane—Phosphatase alkaline increased—Etoposide—muscle cancer	0.000716	0.00745	CcSEcCtD
Dexrazoxane—TOP2A—Vindesine—Vincristine—muscle cancer	0.000714	0.123	CbGdCrCtD
Dexrazoxane—Febrile neutropenia—Methotrexate—muscle cancer	0.000713	0.00742	CcSEcCtD
Dexrazoxane—Oesophagitis—Etoposide—muscle cancer	0.000655	0.00681	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Dactinomycin—muscle cancer	0.000647	0.00673	CcSEcCtD
Dexrazoxane—Hyponatraemia—Vincristine—muscle cancer	0.000645	0.00671	CcSEcCtD
Dexrazoxane—Blood lactate dehydrogenase increased—Doxorubicin—muscle cancer	0.000639	0.00665	CcSEcCtD
Dexrazoxane—Sepsis—Etoposide—muscle cancer	0.000622	0.00647	CcSEcCtD
Dexrazoxane—Dysphagia—Dactinomycin—muscle cancer	0.000621	0.00646	CcSEcCtD
Dexrazoxane—Febrile neutropenia—Doxorubicin—muscle cancer	0.000618	0.00643	CcSEcCtD
Dexrazoxane—Phlebitis—Etoposide—muscle cancer	0.000604	0.00628	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Etoposide—muscle cancer	0.000598	0.00622	CcSEcCtD
Dexrazoxane—Pancytopenia—Dactinomycin—muscle cancer	0.00059	0.00614	CcSEcCtD
Dexrazoxane—Neutropenia—Dactinomycin—muscle cancer	0.000581	0.00604	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Vincristine—muscle cancer	0.000578	0.00601	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Etoposide—muscle cancer	0.000573	0.00597	CcSEcCtD
Dexrazoxane—Pneumonia—Dactinomycin—muscle cancer	0.000557	0.00579	CcSEcCtD
Dexrazoxane—Stomatitis—Dactinomycin—muscle cancer	0.00054	0.00562	CcSEcCtD
Dexrazoxane—Hypercalcaemia—Doxorubicin—muscle cancer	0.000535	0.00556	CcSEcCtD
Dexrazoxane—Pancytopenia—Vincristine—muscle cancer	0.000527	0.00548	CcSEcCtD
Dexrazoxane—Neutropenia—Vincristine—muscle cancer	0.000519	0.0054	CcSEcCtD
Dexrazoxane—Agranulocytosis—Dactinomycin—muscle cancer	0.000517	0.00538	CcSEcCtD
Dexrazoxane—Vaginal haemorrhage—Doxorubicin—muscle cancer	0.000502	0.00522	CcSEcCtD
Dexrazoxane—Weight decreased—Vincristine—muscle cancer	0.000502	0.00522	CcSEcCtD
Dexrazoxane—Pneumonia—Vincristine—muscle cancer	0.000498	0.00518	CcSEcCtD
Dexrazoxane—Depression—Vincristine—muscle cancer	0.000493	0.00513	CcSEcCtD
Dexrazoxane—Extravasation—Methotrexate—muscle cancer	0.000492	0.00512	CcSEcCtD
Dexrazoxane—Stomatitis—Vincristine—muscle cancer	0.000482	0.00502	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Etoposide—muscle cancer	0.000459	0.00477	CcSEcCtD
Dexrazoxane—Injection site pain—Doxorubicin—muscle cancer	0.000455	0.00473	CcSEcCtD
Dexrazoxane—TOP2A—Vinorelbine—Vincristine—muscle cancer	0.000451	0.0775	CbGdCrCtD
Dexrazoxane—TOP2A—Podofilox—Etoposide—muscle cancer	0.00045	0.0774	CbGdCrCtD
Dexrazoxane—TOP2A—Teniposide—Etoposide—muscle cancer	0.00045	0.0774	CbGdCrCtD
Dexrazoxane—Dysphagia—Etoposide—muscle cancer	0.000449	0.00468	CcSEcCtD
Dexrazoxane—Alopecia—Dactinomycin—muscle cancer	0.000439	0.00457	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Vincristine—muscle cancer	0.000436	0.00454	CcSEcCtD
Dexrazoxane—Neoplasm malignant—Doxorubicin—muscle cancer	0.000435	0.00453	CcSEcCtD
Dexrazoxane—Erythema—Dactinomycin—muscle cancer	0.000433	0.0045	CcSEcCtD
Dexrazoxane—Pancytopenia—Etoposide—muscle cancer	0.000427	0.00444	CcSEcCtD
Dexrazoxane—Extravasation—Doxorubicin—muscle cancer	0.000426	0.00443	CcSEcCtD
Dexrazoxane—Neutropenia—Etoposide—muscle cancer	0.00042	0.00437	CcSEcCtD
Dexrazoxane—Cardiac disorder—Vincristine—muscle cancer	0.000412	0.00429	CcSEcCtD
Dexrazoxane—Pneumonia—Etoposide—muscle cancer	0.000403	0.00419	CcSEcCtD
Dexrazoxane—Angiopathy—Vincristine—muscle cancer	0.000403	0.00419	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Dactinomycin—muscle cancer	0.000401	0.00418	CcSEcCtD
Dexrazoxane—Infestation NOS—Etoposide—muscle cancer	0.000401	0.00417	CcSEcCtD
Dexrazoxane—Infestation—Etoposide—muscle cancer	0.000401	0.00417	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Vincristine—muscle cancer	0.0004	0.00416	CcSEcCtD
Dexrazoxane—Anaemia—Dactinomycin—muscle cancer	0.0004	0.00416	CcSEcCtD
Dexrazoxane—Blood bilirubin increased—Doxorubicin—muscle cancer	0.000393	0.00409	CcSEcCtD
Dexrazoxane—Alopecia—Vincristine—muscle cancer	0.000392	0.00408	CcSEcCtD
Dexrazoxane—Stomatitis—Etoposide—muscle cancer	0.000391	0.00406	CcSEcCtD
Dexrazoxane—Creatinine increased—Doxorubicin—muscle cancer	0.00039	0.00406	CcSEcCtD
Dexrazoxane—Malaise—Dactinomycin—muscle cancer	0.00039	0.00406	CcSEcCtD
Dexrazoxane—Mental disorder—Vincristine—muscle cancer	0.000389	0.00405	CcSEcCtD
Dexrazoxane—Leukopenia—Dactinomycin—muscle cancer	0.000387	0.00403	CcSEcCtD
Dexrazoxane—Agranulocytosis—Etoposide—muscle cancer	0.000374	0.00389	CcSEcCtD
Dexrazoxane—Sepsis—Methotrexate—muscle cancer	0.000372	0.00387	CcSEcCtD
Dexrazoxane—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.000372	0.00387	CcSEcCtD
Dexrazoxane—Injection site reaction—Doxorubicin—muscle cancer	0.000369	0.00384	CcSEcCtD
Dexrazoxane—Myalgia—Dactinomycin—muscle cancer	0.000368	0.00383	CcSEcCtD
Dexrazoxane—Discomfort—Dactinomycin—muscle cancer	0.000364	0.00379	CcSEcCtD
Dexrazoxane—Anaemia—Vincristine—muscle cancer	0.000357	0.00372	CcSEcCtD
Dexrazoxane—Infection—Dactinomycin—muscle cancer	0.000351	0.00365	CcSEcCtD
Dexrazoxane—Leukopenia—Vincristine—muscle cancer	0.000346	0.0036	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Dactinomycin—muscle cancer	0.000346	0.0036	CcSEcCtD
Dexrazoxane—Oesophagitis—Doxorubicin—muscle cancer	0.00034	0.00353	CcSEcCtD
Dexrazoxane—Anorexia—Dactinomycin—muscle cancer	0.000337	0.0035	CcSEcCtD
Dexrazoxane—Cardiac disorder—Etoposide—muscle cancer	0.000334	0.00347	CcSEcCtD
Dexrazoxane—Myalgia—Vincristine—muscle cancer	0.000329	0.00342	CcSEcCtD
Dexrazoxane—Angiopathy—Etoposide—muscle cancer	0.000326	0.0034	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Etoposide—muscle cancer	0.000324	0.00337	CcSEcCtD
Dexrazoxane—Sepsis—Doxorubicin—muscle cancer	0.000322	0.00335	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000322	0.00335	CcSEcCtD
Dexrazoxane—Alopecia—Etoposide—muscle cancer	0.000318	0.00331	CcSEcCtD
Dexrazoxane—Infection—Vincristine—muscle cancer	0.000313	0.00326	CcSEcCtD
Dexrazoxane—Phlebitis—Doxorubicin—muscle cancer	0.000313	0.00326	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.00031	0.00323	CcSEcCtD
Dexrazoxane—TOP2A—Vinblastine—Vincristine—muscle cancer	0.00031	0.0533	CbGdCrCtD
Dexrazoxane—Nervous system disorder—Vincristine—muscle cancer	0.000309	0.00322	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Vincristine—muscle cancer	0.000309	0.00321	CcSEcCtD
Dexrazoxane—Decreased appetite—Dactinomycin—muscle cancer	0.000307	0.00319	CcSEcCtD
Dexrazoxane—Fatigue—Dactinomycin—muscle cancer	0.000304	0.00317	CcSEcCtD
Dexrazoxane—Pain—Dactinomycin—muscle cancer	0.000302	0.00314	CcSEcCtD
Dexrazoxane—Anorexia—Vincristine—muscle cancer	0.000301	0.00313	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000297	0.00309	CcSEcCtD
Dexrazoxane—Feeling abnormal—Dactinomycin—muscle cancer	0.000291	0.00303	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Etoposide—muscle cancer	0.000291	0.00302	CcSEcCtD
Dexrazoxane—Anaemia—Etoposide—muscle cancer	0.000289	0.00301	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000289	0.003	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000287	0.00299	CcSEcCtD
Dexrazoxane—Insomnia—Vincristine—muscle cancer	0.000285	0.00297	CcSEcCtD
Dexrazoxane—Malaise—Etoposide—muscle cancer	0.000282	0.00294	CcSEcCtD
Dexrazoxane—Breast disorder—Methotrexate—muscle cancer	0.000281	0.00293	CcSEcCtD
Dexrazoxane—Leukopenia—Etoposide—muscle cancer	0.00028	0.00292	CcSEcCtD
Dexrazoxane—Abdominal pain—Dactinomycin—muscle cancer	0.000279	0.0029	CcSEcCtD
Dexrazoxane—Body temperature increased—Dactinomycin—muscle cancer	0.000279	0.0029	CcSEcCtD
Dexrazoxane—Loss of consciousness—Etoposide—muscle cancer	0.000275	0.00286	CcSEcCtD
Dexrazoxane—Decreased appetite—Vincristine—muscle cancer	0.000274	0.00285	CcSEcCtD
Dexrazoxane—Cough—Etoposide—muscle cancer	0.000273	0.00284	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Vincristine—muscle cancer	0.000272	0.00283	CcSEcCtD
Dexrazoxane—Fatigue—Vincristine—muscle cancer	0.000272	0.00283	CcSEcCtD
Dexrazoxane—Hyponatraemia—Doxorubicin—muscle cancer	0.000271	0.00282	CcSEcCtD
Dexrazoxane—Constipation—Vincristine—muscle cancer	0.00027	0.00281	CcSEcCtD
Dexrazoxane—Pain—Vincristine—muscle cancer	0.00027	0.00281	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000265	0.00275	CcSEcCtD
Dexrazoxane—Discomfort—Etoposide—muscle cancer	0.000263	0.00274	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Vincristine—muscle cancer	0.000258	0.00268	CcSEcCtD
Dexrazoxane—Pancytopenia—Methotrexate—muscle cancer	0.000256	0.00266	CcSEcCtD
Dexrazoxane—Infection—Etoposide—muscle cancer	0.000254	0.00264	CcSEcCtD
Dexrazoxane—Asthenia—Dactinomycin—muscle cancer	0.000253	0.00264	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Doxorubicin—muscle cancer	0.000253	0.00263	CcSEcCtD
Dexrazoxane—Neutropenia—Methotrexate—muscle cancer	0.000252	0.00262	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Etoposide—muscle cancer	0.00025	0.0026	CcSEcCtD
Dexrazoxane—Abdominal pain—Vincristine—muscle cancer	0.000249	0.00259	CcSEcCtD
Dexrazoxane—Body temperature increased—Vincristine—muscle cancer	0.000249	0.00259	CcSEcCtD
Dexrazoxane—Skin disorder—Etoposide—muscle cancer	0.000248	0.00258	CcSEcCtD
Dexrazoxane—Breast disorder—Doxorubicin—muscle cancer	0.000244	0.00254	CcSEcCtD
Dexrazoxane—Anorexia—Etoposide—muscle cancer	0.000244	0.00253	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000243	0.00253	CcSEcCtD
Dexrazoxane—Diarrhoea—Dactinomycin—muscle cancer	0.000242	0.00251	CcSEcCtD
Dexrazoxane—Pneumonia—Methotrexate—muscle cancer	0.000241	0.00251	CcSEcCtD
Dexrazoxane—Infestation NOS—Methotrexate—muscle cancer	0.00024	0.0025	CcSEcCtD
Dexrazoxane—Infestation—Methotrexate—muscle cancer	0.00024	0.0025	CcSEcCtD
Dexrazoxane—Depression—Methotrexate—muscle cancer	0.000239	0.00249	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000238	0.00247	CcSEcCtD
Dexrazoxane—Stomatitis—Methotrexate—muscle cancer	0.000234	0.00243	CcSEcCtD
Dexrazoxane—Dysphagia—Doxorubicin—muscle cancer	0.000233	0.00243	CcSEcCtD
Dexrazoxane—Dyspnoea—Etoposide—muscle cancer	0.000228	0.00237	CcSEcCtD
Dexrazoxane—Somnolence—Etoposide—muscle cancer	0.000227	0.00236	CcSEcCtD
Dexrazoxane—Asthenia—Vincristine—muscle cancer	0.000226	0.00236	CcSEcCtD
Dexrazoxane—Vomiting—Dactinomycin—muscle cancer	0.000225	0.00234	CcSEcCtD
Dexrazoxane—Agranulocytosis—Methotrexate—muscle cancer	0.000224	0.00233	CcSEcCtD
Dexrazoxane—Decreased appetite—Etoposide—muscle cancer	0.000222	0.00231	CcSEcCtD
Dexrazoxane—Pancytopenia—Doxorubicin—muscle cancer	0.000221	0.0023	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Etoposide—muscle cancer	0.000221	0.0023	CcSEcCtD
Dexrazoxane—Fatigue—Etoposide—muscle cancer	0.00022	0.00229	CcSEcCtD
Dexrazoxane—Pain—Etoposide—muscle cancer	0.000219	0.00227	CcSEcCtD
Dexrazoxane—Constipation—Etoposide—muscle cancer	0.000219	0.00227	CcSEcCtD
Dexrazoxane—Neutropenia—Doxorubicin—muscle cancer	0.000218	0.00227	CcSEcCtD
Dexrazoxane—TOP2A—Epirubicin—Doxorubicin—muscle cancer	0.000217	0.0374	CbGdCrCtD
Dexrazoxane—TOP2A—Daunorubicin—Doxorubicin—muscle cancer	0.000217	0.0374	CbGdCrCtD
Dexrazoxane—TOP2A—Idarubicin—Doxorubicin—muscle cancer	0.000217	0.0374	CbGdCrCtD
Dexrazoxane—Haemoglobin—Methotrexate—muscle cancer	0.000217	0.00225	CcSEcCtD
Dexrazoxane—Diarrhoea—Vincristine—muscle cancer	0.000216	0.00225	CcSEcCtD
Dexrazoxane—Haemorrhage—Methotrexate—muscle cancer	0.000215	0.00224	CcSEcCtD
Dexrazoxane—Weight decreased—Doxorubicin—muscle cancer	0.000211	0.00219	CcSEcCtD
Dexrazoxane—Feeling abnormal—Etoposide—muscle cancer	0.000211	0.00219	CcSEcCtD
Dexrazoxane—Nausea—Dactinomycin—muscle cancer	0.00021	0.00218	CcSEcCtD
Dexrazoxane—Pneumonia—Doxorubicin—muscle cancer	0.000209	0.00218	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Etoposide—muscle cancer	0.000209	0.00217	CcSEcCtD
Dexrazoxane—Dizziness—Vincristine—muscle cancer	0.000209	0.00217	CcSEcCtD
Dexrazoxane—Infestation NOS—Doxorubicin—muscle cancer	0.000208	0.00216	CcSEcCtD
Dexrazoxane—Infestation—Doxorubicin—muscle cancer	0.000208	0.00216	CcSEcCtD
Dexrazoxane—Urticaria—Etoposide—muscle cancer	0.000203	0.00211	CcSEcCtD
Dexrazoxane—Stomatitis—Doxorubicin—muscle cancer	0.000203	0.00211	CcSEcCtD
Dexrazoxane—Abdominal pain—Etoposide—muscle cancer	0.000202	0.0021	CcSEcCtD
Dexrazoxane—Body temperature increased—Etoposide—muscle cancer	0.000202	0.0021	CcSEcCtD
Dexrazoxane—Vomiting—Vincristine—muscle cancer	0.000201	0.00209	CcSEcCtD
Dexrazoxane—Cardiac disorder—Methotrexate—muscle cancer	0.0002	0.00208	CcSEcCtD
Dexrazoxane—Headache—Vincristine—muscle cancer	0.000198	0.00206	CcSEcCtD
Dexrazoxane—Angiopathy—Methotrexate—muscle cancer	0.000196	0.00203	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Methotrexate—muscle cancer	0.000194	0.00202	CcSEcCtD
Dexrazoxane—Agranulocytosis—Doxorubicin—muscle cancer	0.000194	0.00202	CcSEcCtD
Dexrazoxane—Alopecia—Methotrexate—muscle cancer	0.00019	0.00198	CcSEcCtD
Dexrazoxane—Mental disorder—Methotrexate—muscle cancer	0.000189	0.00196	CcSEcCtD
Dexrazoxane—Malnutrition—Methotrexate—muscle cancer	0.000188	0.00195	CcSEcCtD
Dexrazoxane—Erythema—Methotrexate—muscle cancer	0.000188	0.00195	CcSEcCtD
Dexrazoxane—Haemoglobin—Doxorubicin—muscle cancer	0.000188	0.00195	CcSEcCtD
Dexrazoxane—Nausea—Vincristine—muscle cancer	0.000187	0.00195	CcSEcCtD
Dexrazoxane—Haemorrhage—Doxorubicin—muscle cancer	0.000187	0.00194	CcSEcCtD
Dexrazoxane—Oedema peripheral—Doxorubicin—muscle cancer	0.000184	0.00191	CcSEcCtD
Dexrazoxane—Asthenia—Etoposide—muscle cancer	0.000183	0.00191	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Doxorubicin—muscle cancer	0.000183	0.00191	CcSEcCtD
Dexrazoxane—Pruritus—Etoposide—muscle cancer	0.000181	0.00188	CcSEcCtD
Dexrazoxane—Diarrhoea—Etoposide—muscle cancer	0.000175	0.00182	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Methotrexate—muscle cancer	0.000174	0.00181	CcSEcCtD
Dexrazoxane—Anaemia—Methotrexate—muscle cancer	0.000173	0.0018	CcSEcCtD
Dexrazoxane—Cardiac disorder—Doxorubicin—muscle cancer	0.000173	0.0018	CcSEcCtD
Dexrazoxane—Angiopathy—Doxorubicin—muscle cancer	0.000169	0.00176	CcSEcCtD
Dexrazoxane—Malaise—Methotrexate—muscle cancer	0.000169	0.00176	CcSEcCtD
Dexrazoxane—Dizziness—Etoposide—muscle cancer	0.000169	0.00176	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Doxorubicin—muscle cancer	0.000168	0.00175	CcSEcCtD
Dexrazoxane—Leukopenia—Methotrexate—muscle cancer	0.000168	0.00175	CcSEcCtD
Dexrazoxane—Alopecia—Doxorubicin—muscle cancer	0.000165	0.00172	CcSEcCtD
Dexrazoxane—Cough—Methotrexate—muscle cancer	0.000164	0.0017	CcSEcCtD
Dexrazoxane—Mental disorder—Doxorubicin—muscle cancer	0.000163	0.0017	CcSEcCtD
Dexrazoxane—Vomiting—Etoposide—muscle cancer	0.000163	0.00169	CcSEcCtD
Dexrazoxane—Erythema—Doxorubicin—muscle cancer	0.000162	0.00169	CcSEcCtD
Dexrazoxane—Malnutrition—Doxorubicin—muscle cancer	0.000162	0.00169	CcSEcCtD
Dexrazoxane—Headache—Etoposide—muscle cancer	0.00016	0.00167	CcSEcCtD
Dexrazoxane—Myalgia—Methotrexate—muscle cancer	0.00016	0.00166	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000159	0.00165	CcSEcCtD
Dexrazoxane—Discomfort—Methotrexate—muscle cancer	0.000158	0.00164	CcSEcCtD
Dexrazoxane—Infection—Methotrexate—muscle cancer	0.000152	0.00158	CcSEcCtD
Dexrazoxane—Nausea—Etoposide—muscle cancer	0.000152	0.00158	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Doxorubicin—muscle cancer	0.000151	0.00157	CcSEcCtD
Dexrazoxane—Nervous system disorder—Methotrexate—muscle cancer	0.00015	0.00156	CcSEcCtD
Dexrazoxane—Anaemia—Doxorubicin—muscle cancer	0.00015	0.00156	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Methotrexate—muscle cancer	0.00015	0.00156	CcSEcCtD
Dexrazoxane—Skin disorder—Methotrexate—muscle cancer	0.000149	0.00155	CcSEcCtD
Dexrazoxane—Malaise—Doxorubicin—muscle cancer	0.000146	0.00152	CcSEcCtD
Dexrazoxane—Anorexia—Methotrexate—muscle cancer	0.000146	0.00152	CcSEcCtD
Dexrazoxane—Syncope—Doxorubicin—muscle cancer	0.000146	0.00152	CcSEcCtD
Dexrazoxane—Leukopenia—Doxorubicin—muscle cancer	0.000145	0.00151	CcSEcCtD
Dexrazoxane—Loss of consciousness—Doxorubicin—muscle cancer	0.000143	0.00149	CcSEcCtD
Dexrazoxane—Cough—Doxorubicin—muscle cancer	0.000142	0.00147	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000139	0.00145	CcSEcCtD
Dexrazoxane—Insomnia—Methotrexate—muscle cancer	0.000138	0.00144	CcSEcCtD
Dexrazoxane—Myalgia—Doxorubicin—muscle cancer	0.000138	0.00144	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000137	0.00143	CcSEcCtD
Dexrazoxane—Discomfort—Doxorubicin—muscle cancer	0.000137	0.00142	CcSEcCtD
Dexrazoxane—Dyspnoea—Methotrexate—muscle cancer	0.000136	0.00142	CcSEcCtD
Dexrazoxane—Somnolence—Methotrexate—muscle cancer	0.000136	0.00142	CcSEcCtD
Dexrazoxane—Dry mouth—Doxorubicin—muscle cancer	0.000135	0.00141	CcSEcCtD
Dexrazoxane—Decreased appetite—Methotrexate—muscle cancer	0.000133	0.00138	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000132	0.00138	CcSEcCtD
Dexrazoxane—Fatigue—Methotrexate—muscle cancer	0.000132	0.00137	CcSEcCtD
Dexrazoxane—Infection—Doxorubicin—muscle cancer	0.000132	0.00137	CcSEcCtD
Dexrazoxane—Pain—Methotrexate—muscle cancer	0.000131	0.00136	CcSEcCtD
Dexrazoxane—Shock—Doxorubicin—muscle cancer	0.00013	0.00136	CcSEcCtD
Dexrazoxane—Nervous system disorder—Doxorubicin—muscle cancer	0.00013	0.00135	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Doxorubicin—muscle cancer	0.00013	0.00135	CcSEcCtD
Dexrazoxane—Skin disorder—Doxorubicin—muscle cancer	0.000129	0.00134	CcSEcCtD
Dexrazoxane—Anorexia—Doxorubicin—muscle cancer	0.000126	0.00131	CcSEcCtD
Dexrazoxane—Feeling abnormal—Methotrexate—muscle cancer	0.000126	0.00131	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Methotrexate—muscle cancer	0.000125	0.0013	CcSEcCtD
Dexrazoxane—Urticaria—Methotrexate—muscle cancer	0.000122	0.00127	CcSEcCtD
Dexrazoxane—Abdominal pain—Methotrexate—muscle cancer	0.000121	0.00126	CcSEcCtD
Dexrazoxane—Body temperature increased—Methotrexate—muscle cancer	0.000121	0.00126	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000121	0.00126	CcSEcCtD
Dexrazoxane—Insomnia—Doxorubicin—muscle cancer	0.00012	0.00125	CcSEcCtD
Dexrazoxane—Dyspnoea—Doxorubicin—muscle cancer	0.000118	0.00123	CcSEcCtD
Dexrazoxane—Somnolence—Doxorubicin—muscle cancer	0.000118	0.00123	CcSEcCtD
Dexrazoxane—Decreased appetite—Doxorubicin—muscle cancer	0.000115	0.0012	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000114	0.00119	CcSEcCtD
Dexrazoxane—Fatigue—Doxorubicin—muscle cancer	0.000114	0.00119	CcSEcCtD
Dexrazoxane—Constipation—Doxorubicin—muscle cancer	0.000113	0.00118	CcSEcCtD
Dexrazoxane—Pain—Doxorubicin—muscle cancer	0.000113	0.00118	CcSEcCtD
Dexrazoxane—Asthenia—Methotrexate—muscle cancer	0.00011	0.00114	CcSEcCtD
Dexrazoxane—Feeling abnormal—Doxorubicin—muscle cancer	0.000109	0.00114	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000108	0.00113	CcSEcCtD
Dexrazoxane—Pruritus—Methotrexate—muscle cancer	0.000108	0.00113	CcSEcCtD
Dexrazoxane—Urticaria—Doxorubicin—muscle cancer	0.000105	0.0011	CcSEcCtD
Dexrazoxane—Abdominal pain—Doxorubicin—muscle cancer	0.000105	0.00109	CcSEcCtD
Dexrazoxane—Body temperature increased—Doxorubicin—muscle cancer	0.000105	0.00109	CcSEcCtD
Dexrazoxane—Diarrhoea—Methotrexate—muscle cancer	0.000105	0.00109	CcSEcCtD
Dexrazoxane—Dizziness—Methotrexate—muscle cancer	0.000101	0.00105	CcSEcCtD
Dexrazoxane—Vomiting—Methotrexate—muscle cancer	9.73e-05	0.00101	CcSEcCtD
Dexrazoxane—Headache—Methotrexate—muscle cancer	9.59e-05	0.000998	CcSEcCtD
Dexrazoxane—Asthenia—Doxorubicin—muscle cancer	9.51e-05	0.00099	CcSEcCtD
Dexrazoxane—Pruritus—Doxorubicin—muscle cancer	9.38e-05	0.000976	CcSEcCtD
Dexrazoxane—Nausea—Methotrexate—muscle cancer	9.09e-05	0.000946	CcSEcCtD
Dexrazoxane—Diarrhoea—Doxorubicin—muscle cancer	9.07e-05	0.000944	CcSEcCtD
Dexrazoxane—Dizziness—Doxorubicin—muscle cancer	8.77e-05	0.000912	CcSEcCtD
Dexrazoxane—Vomiting—Doxorubicin—muscle cancer	8.43e-05	0.000877	CcSEcCtD
Dexrazoxane—Headache—Doxorubicin—muscle cancer	8.31e-05	0.000864	CcSEcCtD
Dexrazoxane—Nausea—Doxorubicin—muscle cancer	7.87e-05	0.000819	CcSEcCtD
